Clinical Features, Laboratory Parameters, Treatment and Outcome analysis of COVID-19 Patients admitted to a Referral Hospital at Nepalese Terai Region during Second Wave

Simple item page
dc.contributor.authorMishra, R.en_US
dc.contributor.authorSingh, J. K.en_US
dc.contributor.authorJha, B. K.en_US
dc.contributor.authorPriya, K.en_US
dc.contributor.authorKhanal, A.en_US
dc.contributor.authorAnand, A.en_US
dc.contributor.authorYadav, A. K.en_US
dc.date.accessioned2024-12-02T07:23:53Z
dc.date.available2024-12-02T07:23:53Z
dc.date.issued2023-08
dc.description.abstractBackground & Objective: COVID-19 pandemic has tested health care systems worldwide. The massive wave of infection in Nepal between March to April 2021 overwhelmed the health care institutions throughout the country. This study describes the demographic, clinical, laboratory parameters and outcome of patients hospitalized in a secondary level facility during second wave of infection. Material and Methods: The data was extracted from admitted patients at Janaki Health Care and Teaching Hospital (JHCTH) with COVID-19, between 9th April to 14th June 2021. Demographic, clinical, laboratory parameters, treatment and outcome were recorded from the medical records and analyzed. Results: Out of 122 admitted patients,11%, 18.03%, 33.60% and 35.24% presented with mild, moderate, severe and critical illnesses respectively, with the median saturation of peripheral oxygen (SPO2) at admission was 89(34-99)% and 17 deaths were recorded a mortality rate of 20.4%.A significantly high mortality rate was found among ventilated patients (73.3%), against non ventilated (7.2%). Mortality rates among critically and severely ill patients were 38.46 % and 6.9% respectively. Mean C reactive protein (CRP) was 51.13(±30.50)mg/dl. Statistically significant CRP levels were observed in patients who presented with mild illness (32.53±10.85 mg/dl) and those who died in hospital (61.08±30.00 mg/dl). Remdesivir use did not offer any mortality benefit. Conclusion: A very high mortality rate (20.40%) observed in this study due to COVID-19 in hospitalized patients, may be associated with a high proportion of severe and critical cases (68.70%) admitted. Further upgrading of health resources should be prioritized to manage severe COVID-19 related mortalities, because of the possibility of a future waves.en_US
dc.identifier.affiliationsAssistant Professor, Department of Medicine, Janaki Medical College, Tribhuvan University, Janakpur, Nepalen_US
dc.identifier.affiliationsAssociate Professor, Department of Community Medicine, Janaki Medical College, Tribhuvan University, Janakpur, Nepalen_US
dc.identifier.affiliationsAssistant Professor, Department of Biochemistry, Janaki Medical College, Tribhuvan University, Janakpur, Nepalen_US
dc.identifier.affiliationsMedical officer, Department of Medicine, Janaki Healthcare and Teaching Hospital, Janakpur, Nepalen_US
dc.identifier.affiliationsMedical officer, Department of General Practice and Emergency Medicine, Patan Academy of Health Sciences, Lalitpur, Nepal & Department of Critical Care Medicine, Alka Hospital ,Lalitpur, Nepalen_US
dc.identifier.affiliationsMBBS Intern, Nepal Medical College and Teaching Hospital, Kathmandu University, Kathmandu, Nepalen_US
dc.identifier.affiliationsMedical officer, Department of Internal Medicine, Provincial Hospital, Madhesh Province, Janakpurdham, Nepalen_US
dc.identifier.citationMishra R., Singh J. K., Jha B. K., Priya K., Khanal A., Anand A., Yadav A. K.. Assessment of Polypharmacy among Diabetic Patients in Tertiary Care Hospital of Nepal . Janaki Medical College Journal of Medical Science. 2023 May; 11(2): 9-17en_US
dc.identifier.issn2091-2242
dc.identifier.issn2091-2358
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/239135
dc.languageenen_US
dc.publisherJanaki Medical Collegeen_US
dc.relation.issuenumber2en_US
dc.relation.volume11en_US
dc.source.urihttps://doi.org/10.3126/jmcjms.v11i2.58024en_US
dc.subjectCOVID-19en_US
dc.subjectC- reactive proteinen_US
dc.subjectin-patienten_US
dc.subjectMortalityen_US
dc.subjectRemdesiviren_US
dc.titleClinical Features, Laboratory Parameters, Treatment and Outcome analysis of COVID-19 Patients admitted to a Referral Hospital at Nepalese Terai Region during Second Waveen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
jmcjms2023v11n2p9.pdf
Size:
977.69 KB
Format:
Adobe Portable Document Format
Download
Collections
Janaki Medical College Journal of Medical Science